Hemoglobin H disease

From WikiMD's WELLNESSPEDIA


Hemoglobin H disease
Synonyms HbH disease
Pronounce N/A
Specialty N/A
Symptoms Anemia, jaundice, splenomegaly, fatigue
Complications Iron overload, gallstones, heart failure
Onset Usually in childhood
Duration Lifelong
Types N/A
Causes Genetic mutation in the alpha-globin gene
Risks Family history of thalassemia
Diagnosis Blood test, genetic testing
Differential diagnosis Beta thalassemia, sickle cell disease
Prevention Genetic counseling
Treatment Blood transfusion, iron chelation therapy, folic acid supplementation
Medication N/A
Prognosis Variable, depends on severity
Frequency More common in Southeast Asia, Mediterranean, Middle East
Deaths N/A


Hemoglobin H disease is a form of alpha thalassemia, a genetic blood disorder that affects the production of hemoglobin. Hemoglobin is the protein in red blood cells responsible for carrying oxygen throughout the body. Hemoglobin H disease is characterized by the presence of an abnormal form of hemoglobin known as hemoglobin H (HbH).

Pathophysiology[edit]

Hemoglobin H disease occurs due to the deletion or mutation of three out of the four alpha-globin genes. The alpha-globin genes are responsible for producing the alpha-globin chains that form part of the hemoglobin molecule. In individuals with Hemoglobin H disease, the lack of sufficient alpha-globin chains leads to the formation of abnormal hemoglobin composed of beta-globin chains, known as hemoglobin H.

Symptoms[edit]

The symptoms of Hemoglobin H disease can vary widely but often include:

Diagnosis[edit]

Diagnosis of Hemoglobin H disease typically involves:

Treatment[edit]

There is no cure for Hemoglobin H disease, but treatment focuses on managing symptoms and preventing complications. Treatment options may include:

Prognosis[edit]

The prognosis for individuals with Hemoglobin H disease varies. Some individuals may experience mild symptoms, while others may have more severe complications. Regular medical follow-up and appropriate management can help improve the quality of life for affected individuals.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.